Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Railcare Group | RAIL | 17. avr 2024 | 25.50 | +0.39 |
Railway Metrics and Dynamics Sweden AB | RMDX | 17. avr 2024 | 2.30 | +17.95 |
Raketech | RAKE | 17. avr 2024 | 13.60 | -2.72 |
Rana Gruber ASA | RANAO | 17. avr 2024 | 81.60 | -1.33 |
RanLOS | RLOSB | 17. avr 2024 | 7.08 | 0.00 |
Ranplan Group | RPLAN | 17. avr 2024 | 1.10 | 0.00 |
Ratos A | RATOA | 17. avr 2024 | 35.70 | +0.56 |
Ratos B | RATOB | 17. avr 2024 | 33.72 | +0.24 |
RaySearch Laboratories B | RAYB | 17. avr 2024 | 116.60 | +0.87 |
Raytelligence | RAYTL | 17. avr 2024 | 0.00 | -40.00 |
Readly International | READ | 17. avr 2024 | 14.30 | +0.35 |
Real Fastigheter AB | REAL | 17. avr 2024 | 8.48 | 0.00 |
RealFiction | REALFI | 17. avr 2024 | 13.90 | -1.42 |
Recyctec B | RECYB | 17. avr 2024 | 0.62 | 0.00 |
Rederi Gotland AB | GOTLA | 17. avr 2024 | 2 040.00 | 0.00 |
Rederi Gotland AB. ser. B | GOTLB | 17. avr 2024 | 2 020.00 | 0.00 |
Redsense Medical | REDS | 17. avr 2024 | 5.16 | -6.18 |
Redwood Pharma | REDW | 17. avr 2024 | 1.34 | +4.71 |
Refine Group | REFINE | 17. avr 2024 | 2.52 | +5.88 |
Rejlers B | REJLB | 17. avr 2024 | 137.00 | -0.72 |
Renewable Ventures Nordic | RVN | 17. avr 2024 | 7.50 | +20.00 |
Rentunder Holding | RENT | 17. avr 2024 | 0.32 | +3.90 |
Respiratorius | RESP | 17. avr 2024 | 0.33 | -3.19 |
Resqunit | RESQ | 17. avr 2024 | 0.51 | 0.00 |
Resurs Holding | RESURS | 17. avr 2024 | 15.01 | +0.47 |
Revolutionrace | RVRC | 17. avr 2024 | 62.70 | -0.95 |
RightBridge Ventures Group | RIGHTB | 17. avr 2024 | 0.04 | -1.53 |
Rolling Optics Holding | RO | 17. avr 2024 | 0.92 | -8.91 |
Rottneros | RROS | 17. avr 2024 | 11.92 | -0.50 |
RugVista Group | RUG | 17. avr 2024 | 67.20 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.